Search results for " guidance"
								 					Article
				
				Managing Residual Impurities During Downstream Processing
								“As biologic manufacturing and biologic product knowledge continue to expand, there will be a constant requirement to adapt and amend both thought processes and guidance,” Wake states.
	Role of publ…								
								 					Article
				
				Efforts Accelerate to Streamline Postapproval Change Process
								To spur the Q12 process, FDA in 2015 issued a draft guidance on defining and reporting ECs (2). The guidance describes which elements of a control strategy could be considered ECs necessary to assure …								
								 					Article
				
				The Metrics of Quality Culture
								Schniepp 
	The long awaited, anxiously anticipated FDA guidance on quality metrics was finally distributed for comment on July 28, 2015. The official title of this guidance for industry is Request f…								
								 					Article
				
				Determining Criticality–Process Parameters and Quality Attributes Part III: Process Control Strategies—Criticality throughout the Lifecycle
								With the most recent FDA (1) and Inter-national Conference on Har-monization (ICH) guidances (2-4) advocating a new paradigm of process validation based on process understanding and control of paramet…								
								 					Article
				
				The Lifecycle Change of Process Validation and Analytical Testing
								…ical services director, of Innopharma Labs in Dublin, about the impact FDA's 2011 process validation guidance has had on analytical testing and validation.  
	
	
	
	  
	
		CONTINUOUS PROCESS VERI…								
								 					Article
				
				Successfully Moving Regulated Data to the Cloud
								Changing working practices and regulations
	One example from FDA’s guidance document describes the use of shared login accounts. Previously, shared accounts have been used to conveniently access a r…								
								 					Article
				
				Putting Viral Clearance Capabilities to the Test
								The model viruses used, and the number of steps investigated for viral clearance capacity, should be related to the risk assessment and product-specific regulatory guidance, says Horst Ruppach, direct…								
								 					Article
				
				Transformative Medicines Challenge FDA and Manufacturers
								…ce on combination products, also in October in Bethesda, MD, highlighting efforts to update existing guidances and to prepare additional advisories on labeling issues and bridging studies.  
	
	
		A …								
								 					Article
				
				Evaluating Surface Cleanliness Using a Risk-Based Approach
								Cleaning validation regulatory guidance
	
		FDA’s 1998 cleaning validation guidance document focuses on general aspects and qualification of the cleaning process (1). The design and post-validation mo…								
								 					Article
				
				Framing Biopharma Success in 2016
								To encourage manufacturers to adopt new production technologies, FDA issued a draft guidance document (5) in December 2015 that provides a framework for drug manufacturers and FDA to discuss manufactu…